Palo Alto's life sciences community brings together scientific entrepreneurs, research institutions, investors, and companies developing biotechnology, precision medicine, medical devices, diagnostics, and digital health technologies. Stanford Research Park's Life Science District and nearby startup incubators provide an environment where discoveries can progress from academic laboratories toward commercial products, therapies, devices, and treatments.
At Torrey Pines Law Group, we guide pharmaceutical, medical device, diagnostic, biotechnology, and digital health companies through the complex regulatory landscape of the FDA. One of the many things that distinguishes our firm is our experience and ability to advise on the interaction between patent portfolio development and FDA regulatory strategy.
Our team has substantial experience with facets of the international FDA regulatory approval and clearance processes, including:
Our strategic consultations employ key knowledge in the areas of FDA regulatory strategy, clinical development, product design, quality compliance, patent strategy, commercialization, and overall development feasibility. We help clients evaluate regulatory pathways for pharmaceuticals, biologics, medical devices, diagnostics, software, and other regulated products.
If you are seeking to clear a medical device or approve a drug through the US Food & Drug Administration (FDA), or through international counterparts such as Europe (EMA), China (NMPA), Japan (PMDA), Health Canada, Australia (TGA), or India (DCGI), we can help you. In addition, if you are developing a reimbursement strategy to support payment for your medical device, drug, diagnostic, or other regulated product, we are part of a trusted network of specialists who can guide you.
Our regulatory advisors, reimbursement specialists, and network of Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and business advisors have the experience to help you define multiple paths to market through international regulatory and reimbursement bodies. If you need Palo Alto FDA regulatory counsel to help you with your domestic or international regulatory and reimbursement matters, please contact us for our complimentary initial consultation to discuss your matter.
COPYRIGHT ©
, TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP
| Standard Firm Charges
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.